APA aipamena

Olliaro, P., Kuesel, A., Halleux, C., Sullivan, M., & Reeder, J. (2018). Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years. Public Library of Science.

Chicago Style aipamena

Olliaro, P., A. Kuesel, C. Halleux, M. Sullivan, and J. Reeder. Creative Use of the Priority Review Voucher by Public and Not-for-profit Actors Delivers the First New FDA-approved Treatment for River Blindness in 20 Years. Public Library of Science, 2018.

MLA aipamena

Olliaro, P., et al. Creative Use of the Priority Review Voucher by Public and Not-for-profit Actors Delivers the First New FDA-approved Treatment for River Blindness in 20 Years. Public Library of Science, 2018.